12:00 AM
 | 
Oct 01, 2012
 |  BC Week In Review  |  Company News  |  Other News

Questcor autoimmune, renal, neurology news

Questcor said the U.S. government is investigating the company's promotional practices. Questcor said it intends to cooperate with the investigation but declined to provide details. Questcor markets H.P. Acthar Gel repository corticotropin injection in the U.S. for 19 indications. However the company generates "substantially all" of its net sales...

Read the full 233 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >